These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23186457)

  • 1. Anthony P. Millar on Michael Bahrke's Performance-enhancing substance misuse in sport: risk factors and considerations for intervention programs.
    Millar AP
    Subst Use Misuse; 2012; 47(13-14):1519-20. PubMed ID: 23186457
    [No Abstract]   [Full Text] [Related]  

  • 2. Azenildo Moura Santos on Michael Bahrke's "Performance-enhancing substance misuse in sport: risk factors and considerations for success and failure in intervention programs".
    Santos AM
    Subst Use Misuse; 2012; 47(13-14):1517-8. PubMed ID: 23186456
    [No Abstract]   [Full Text] [Related]  

  • 3. Stan Reents on Mike Bahrke's "Performance-enhancing substance misuse in sport: intervention programs". Testing for doping: pitfalls.
    Reents S
    Subst Use Misuse; 2012; 47(13-14):1521-2. PubMed ID: 23186458
    [No Abstract]   [Full Text] [Related]  

  • 4. Performance-enhancing substance misuse in sport: risk factors and considerations for success and failure in intervention programs.
    Bahrke MS
    Subst Use Misuse; 2012; 47(13-14):1505-16. PubMed ID: 23186455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sports psychiatrist and performance-enhancing drugs.
    Creado S; Reardon C
    Int Rev Psychiatry; 2016 Dec; 28(6):564-571. PubMed ID: 27310472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What if it really was an accident? The psychology of unintentional doping.
    Chan DK; Ntoumanis N; Gucciardi DF; Donovan RJ; Dimmock JA; Hardcastle SJ; Hagger MS
    Br J Sports Med; 2016 Aug; 50(15):898-9. PubMed ID: 26392593
    [No Abstract]   [Full Text] [Related]  

  • 7. Success, Failure, and Unfinished Business of Education, Prevention, Policy, and Intervention Programs on Substance Misuse in Brazilian Sport.
    Santos AM
    Subst Use Misuse; 2015; 50(8-9):1139-43. PubMed ID: 26361918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should athletes be allowed to use performance enhancing drugs?
    Savulescu J; Creaney L; Vondy A
    BMJ; 2013 Oct; 347():f6150. PubMed ID: 24149520
    [No Abstract]   [Full Text] [Related]  

  • 9. [Daily doping. Higher, faster, stronger].
    Taillens F
    Krankenpfl Soins Infirm; 2012; 105(2):40-3, 62-5. PubMed ID: 22339004
    [No Abstract]   [Full Text] [Related]  

  • 10. Performance-enhancing substances in sports: a review of the literature.
    Momaya A; Fawal M; Estes R
    Sports Med; 2015 Apr; 45(4):517-31. PubMed ID: 25663250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: a position statement of the sport cardiology and exercise nucleus of the European Association of Preventive Cardiology.
    Adami PE; Koutlianos N; Baggish A; Bermon S; Cavarretta E; Deligiannis A; Furlanello F; Kouidi E; Marques-Vidal P; Niebauer J; Pelliccia A; Sharma S; Solberg EE; Stuart M; Papadakis M
    Eur J Prev Cardiol; 2022 Mar; 29(3):559-575. PubMed ID: 35081615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recreational and ergogenic substance use and substance use disorders in elite athletes: a narrative review.
    McDuff D; Stull T; Castaldelli-Maia JM; Hitchcock ME; Hainline B; Reardon CL
    Br J Sports Med; 2019 Jun; 53(12):754-760. PubMed ID: 31097457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Control of doping. That is relevant for more than Olympic competitors].
    Bischoff M
    MMW Fortschr Med; 2012 Jul; 154(13):23. PubMed ID: 22957374
    [No Abstract]   [Full Text] [Related]  

  • 14. A call for policy guidance on psychometric testing in doping control in sport.
    Petróczi A; Backhouse SH; Barkoukis V; Brand R; Elbe AM; Lazuras L; Lucidi F
    Int J Drug Policy; 2015 Nov; 26(11):1130-9. PubMed ID: 26094122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abuse of medicines for performance enhancement in sport: why is this a problem for the pharmaceutical industry?
    Elliott S; Leishman B
    Bioanalysis; 2012 Jul; 4(13):1681-90. PubMed ID: 22831483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anti-doping sampling strategy utilizing the sewerage systems of sport villages.
    Katsoyiannis A; Jones KC
    Environ Sci Technol; 2011 Jan; 45(2):362-3. PubMed ID: 21142144
    [No Abstract]   [Full Text] [Related]  

  • 17. Predicting attitude towards performance enhancing substance use: a comprehensive test of the Sport Drug Control Model with elite Australian athletes.
    Jalleh G; Donovan RJ; Jobling I
    J Sci Med Sport; 2014 Nov; 17(6):574-9. PubMed ID: 24268440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug misuse in sport: a New Zealand perspective.
    Curtis A; Gerrard D; Burt P; Osborne H
    N Z Med J; 2015 Dec; 128(1426):62-8. PubMed ID: 26913908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Organic injuries in doped elite sports men].
    Vitoria Ortiz M
    An R Acad Nac Med (Madr); 2010; 127(2):289-302; discussion 303-5. PubMed ID: 21877411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and Development of the List of Prohibited Substances and Methods.
    Kinahan A; Budgett R; Mazzoni I
    Med Sport Sci; 2017; 62():39-54. PubMed ID: 28571027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.